Evidence map›Paper›PMID 38293169›Full record

ArticlebioRxiv : the preprint server for biology2025

Modeling and Design of Chitosan-PCL Bi-Layered Microspheres for Intravitreal Controlled Release.

Eduardo A Chacin Ruiz, Samantha L Carpenter, Katelyn E Swindle-Reilly, Ashlee N Ford Versypt

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Eduardo A Chacin Ruiz
Samantha L Carpenter
Katelyn E Swindle-Reilly
Ashlee N Ford VersyptORCID 0000-0001-9059-5703

Funding

Quantitative Systems Biomedicine and Pharmacology for Multiscale Tissue DamageR35GM133763 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Ashlee Nicole Ford Versypt · 2019 to 2026
$2.7M
Predictive Drug Release from a Tunable Injectable CapsuleR01EB032870 · NIBIB · OHIO STATE UNIVERSITY · PI Nagaraj Kerur · 2023 to 2026
$2.1M
NIBIB NIH HHS R01 EB032870NIGMS NIH HHS R35 GM133763
6 · The paper itself

Abstract

Chronic retinal diseases usually require repetitive local dosing. Depending on factors such as dosing frequency, mode of administration, and associated costs, this can result in poor patient compliance. A better alternative involves using controlled release drug delivery systems to reduce the frequency of intravitreal dosing and extend drug release. However, reaching the market stage is a time-consuming process. In this study, we employed two computational approaches to model and estimate the parameters governing the diffusion-controlled drug release of bovine serum albumin and bevacizumab (an agent that slows neovascularization due to retinal disorders) from bi-layered core-shell microspheres composed of chitosan and polycaprolactone (PCL). We used the estimated parameters to simulate the cumulative release under various conditions, optimize device design to guide future experimental efforts and improve the duration of release above a target daily therapeutic release rate from the microspheres. We investigated the effects of polymeric layer sizes on drug release. We provided straightforward computational tools for others to reuse in designing bi-layered microspheres suitable for addressing intravitreal drug delivery needs in the treatment of ocular neovascularization in chronic retinal diseases.

Identifiers

PMID38293169
PMCPMC10827073

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.